- cafead   Aug 02, 2022 at 11:32: PM
via A federal appeals court ruled in AbbVie’s favor on Monday, upholding an Illinois court’s decision to dismiss allegations that the pharma giant created an unlawful “patent thicket” around its blockbuster drug Humira.
article source
article source